Zejun Fang

806 total citations
27 papers, 548 citations indexed

About

Zejun Fang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zejun Fang has authored 27 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Zejun Fang's work include Epigenetics and DNA Methylation (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related Molecular Pathways (5 papers). Zejun Fang is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related Molecular Pathways (5 papers). Zejun Fang collaborates with scholars based in China, United States and France. Zejun Fang's co-authors include Chaoju Gong, Min Lin, Yanyan Hu, Chunxiao Li, Hong Liu, Hong Liu, Zhongchao Han, Hongzhang Li, Min Lin and Xi Xu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Zejun Fang

24 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zejun Fang China	15	381	196	169	77	58	27	548
Chaoju Gong China	14	364 1.0×	216 1.1×	211 1.2×	80 1.0×	73 1.3×	28	619
Qicong Luo China	13	464 1.2×	261 1.3×	158 0.9×	92 1.2×	64 1.1×	22	656
Hiroki Ueo Japan	13	348 0.9×	206 1.1×	173 1.0×	57 0.7×	36 0.6×	28	501
Mingxin Wen China	10	520 1.4×	229 1.2×	167 1.0×	47 0.6×	42 0.7×	17	615
Yanmei Cui China	13	450 1.2×	333 1.7×	138 0.8×	77 1.0×	70 1.2×	16	641
Alan Ka‐Lun Kai Hong Kong	6	361 0.9×	310 1.6×	125 0.7×	52 0.7×	47 0.8×	6	513
Junwei Song China	14	547 1.4×	287 1.5×	137 0.8×	81 1.1×	64 1.1×	18	712
Honggang Yu China	16	400 1.0×	225 1.1×	152 0.9×	72 0.9×	59 1.0×	22	605
Zhuqing Zhou China	14	329 0.9×	205 1.0×	150 0.9×	97 1.3×	34 0.6×	26	529

Countries citing papers authored by Zejun Fang

Since Specialization

Citations

This map shows the geographic impact of Zejun Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zejun Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zejun Fang more than expected).

Fields of papers citing papers by Zejun Fang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zejun Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zejun Fang. The network helps show where Zejun Fang may publish in the future.

Co-authorship network of co-authors of Zejun Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Zejun Fang. A scholar is included among the top collaborators of Zejun Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zejun Fang. Zejun Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Hangkai, et al.. (2025). Laparoscopically confirmed endometriosis and the risk of incident NAFLD: a prospective cohort study. Reproductive Biology and Endocrinology. 23(1). 55–55.

Lin, Min, Weihua Zhou, Yizhang Wang, et al.. (2024). HDAC5 deacetylates c-Myc and facilitates cell cycle progression in hepatocellular carcinoma cells. Cellular Signalling. 124. 111386–111386. 3 indexed citations

Xu, Xi, Chaoju Gong, Yunfeng Wang, et al.. (2024). FOXF1 promotes ovarian cancer metastasis by facilitating HMGA2-mediated USP30-dependent S100A6 deubiquitination. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167633–167633.

Han, Shanshan, et al.. (2024). E2F1 modulates RCCD1 expression to participate in the initiation and progression of EMT in colorectal cancer. Pathology - Research and Practice. 260. 155429–155429. 4 indexed citations

Lou, Zhiyuan, Lijuan Guo, Hongyan Qi, et al.. (2023). E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinoma. Biochemical Pharmacology. 218. 115854–115854. 6 indexed citations

Yang, Jun J., Zejun Fang, Peng Jin, et al.. (2022). Development and experimental verification of C-arm camera shooting locator. Scientific Reports. 12(1). 22222–22222.

Gong, Chaoju, et al.. (2022). Lipid metabolic features of T cells in the Tumor Microenvironment. Lipids in Health and Disease. 21(1). 94–94. 8 indexed citations

Fang, Zejun, Min Lin, Shenghui Chen, et al.. (2022). E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells. Cellular & Molecular Biology Letters. 27(1). 90–90. 15 indexed citations

Fang, Zejun, et al.. (2022). TOPBP1 regulates resistance of gastric cancer to oxaliplatin by promoting transcription of PARP1. DNA repair. 111. 103278–103278. 9 indexed citations

10.

Yang, Jun, et al.. (2021). Insights Into the Function and Clinical Application of HDAC5 in Cancer Management. Frontiers in Oncology. 11. 661620–661620. 26 indexed citations

11.

Bao, Yuyan, Lei Qiao, Yanyan Hu, et al.. (2021). KIF18b-dependent hypomethylation of PARPBP gene promoter enhances oxaliplatin resistance in colorectal cancer. Experimental Cell Research. 407(2). 112827–112827. 11 indexed citations

12.

Xu, Xi, Chaoju Gong, Yunfeng Wang, et al.. (2020). Multi-Omics Analysis to Identify Driving Factors in Colorectal Cancer. Epigenomics. 12(18). 1633–1650. 14 indexed citations

13.

Gong, Chaoju, Lei Qiao, Qing Xu, et al.. (2020). IL-6-induced acetylation of E2F1 aggravates oxidative damage of retinal pigment epithelial cell line. Experimental Eye Research. 200. 108219–108219. 19 indexed citations

14.

Fang, Zejun, Min Lin, Chunxiao Li, Hong Liu, & Chaoju Gong. (2020). A comprehensive review of the roles of E2F1 in colon cancer.. PubMed. 10(3). 757–768. 74 indexed citations

15.

Fang, Zejun, Hua Yang, Dan Chen, et al.. (2019). YY1 promotes colorectal cancer proliferation through the miR-526b-3p/E2F1 axis.. PubMed. 9(12). 2679–2692. 25 indexed citations

16.

Zhang, Rongwei, et al.. (2019). The TGFβ1-FOXM1-HMGA1-TGFβ1 positive feedback loop increases the cisplatin resistance of non-small cell lung cancer by inducing G6PD expression.. PubMed. 11(11). 6860–6876. 25 indexed citations

17.

Fang, Zejun, Xiang Cai, Rui Song, et al.. (2018). Highly expressed histone deacetylase 5 promotes the growth of hepatocellular carcinoma cells by inhibiting the TAp63-maspin pathway.. PubMed. 8(3). 462–475. 16 indexed citations

18.

Fang, Zejun, Chaoju Gong, Weihua Zhou, et al.. (2017). NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling. Cancer Letters. 415. 58–72. 56 indexed citations

19.

Fang, Zejun, Chaoju Gong, Hong Liu, et al.. (2015). E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2. Biochemical and Biophysical Research Communications. 464(2). 407–415. 50 indexed citations

20.

Fang, Zejun, Rui Song, Chaoju Gong, et al.. (2015). Ribonucleotide reductase large subunit M1 plays a different role in the invasion and metastasis of papillary thyroid carcinoma and undifferentiated thyroid carcinoma. Tumor Biology. 37(3). 3515–3526. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact